Navigation Links
Antiangiogenic Role of 2ME2 Demonstrated in Rheumatoid Arthritis Models
Date:11/3/2008

ROCKVILLE, Md., Nov. 3 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced the publication of preclinical results for 2ME2 (Panzem(R) or 2- methoxyestradiol) in rheumatoid arthritis (RA). The results of the study, conducted by EntreMed collaborator, Dr. Ernest Brahn, Professor of Medicine, Rheumatology Program Director, David Geffen School of Medicine at UCLA, were published in the November 2008 issue of the Journal of Rheumatology (Brahn E, Banquerigo ML, Lee JK, Park EJ, Fogler WE, and Plum SM. An angiogenesis inhibitor, 2-methoxyestradiol, involutes rat collagen-induced arthritis and suppresses synovial VEGF and bFGF gene expression. J Rheumatol 2008;35:2119- 28).

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO )

Results from treatment studies in a preclinical model of established rheumatoid arthritis demonstrated that daily oral administration of 2ME2 suppressed both clinical and radiographic indicators of joint inflammation and damage, including soft tissue swelling and bone erosion. The treatment benefits of 2ME2 were dose-dependent and associated with reduced joint expression of the prominent angiogenic growth factors, FGF-2 and VEGF, as well as decreased angiogenesis. The report further demonstrates both a delay in onset and decrease in severity of arthritis if 2ME2 treatment is started prior to disease initiation. These results indicate that 2ME2 may represent a novel agent for treatment of inflammatory autoimmune diseases such as rheumatoid arthritis and identify 2ME2 as a disease mod
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Volcano Announces Activities at TCT 2007: Expanded Role of IVUS in PCI to be Demonstrated
2. Golimumab Phase 3 Data Show Significant Improvement In Physical Function In Patients with Rheumatoid Arthritis
3. Trubion Reports Re-treatment Results Following Phase 1/2a and Phase 2b Studies Evaluating TRU-015 for Rheumatoid Arthritis
4. Use of Biologic Agents Continues to Expand Among US Rheumatologists - Can New Agents Shift the Treatment Paradigm in Rheumatoid Arthritis?
5. New MedPredict Report Highlights Trend Toward Early Diagnosis and Treatment of Rheumatoid Arthritis, Impact on Pharmaceutical Development
6. Phase 3 studies show golimumab significantly improved signs and symptoms of rheumatoid arthritis
7. Medarex Receives Milestone Payment for Submission of Regulatory Application Requesting Approval of Golimumab (CNTO 148) in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
8. Centocor, Inc. and Schering-Plough Submit Application Requesting Approval of Golimumab in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
9. Unmet Needs Provide Challenges and Opportunities for Rheumatoid Arthritis Drug Developers According to MedPredict Report
10. FDA Agrees to Review Cimzia(R) File for the Treatment of Rheumatoid Arthritis
11. One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... April 21, 2015 Leading-edge ... clinical applications will be presented at the ... scientists, regulators and clinicians from academia, industry ... sponsored by Invibio Biomaterial Solutions. The world-leading ... specialist in manufacturing and R&D for medical-device ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 A leading ... AMERICA is slated to discuss its custom fabrication services ... its reimagined website, which launched just prior to the ... Thurs. (April 21, 22 and 23) at the Javits ... representatives of the world’s largest and most innovative pharmaceutical ...
(Date:4/21/2015)... April 21, 2015 Whether it’s used for ... or bolted to a Kessler CineDrive in a ... the beach, the TS3-H is designed to help any shooter ... brand-new state-of-the-art 5MP sensor, the TS5-H offers the same convenient ... imaging characteristics. , According to Tom Boldt for Fastec, ...
(Date:4/21/2015)... 2015 YourEncore, an Indianapolis, Indiana-based ... consumer products and food sciences industries solve complex ... for Clinical Research Excellence and Safety (ACRES), a ... clinical research, have partnered to speed innovation in ... YourEncore brings to ACRES experts with proven experience, ...
Breaking Biology Technology:2nd International PEEK Meeting: Invibio Biomaterial Solutions spearheads medical research for implantable PEEK polymer devices 22nd International PEEK Meeting: Invibio Biomaterial Solutions spearheads medical research for implantable PEEK polymer devices 3HOLLOWAY AMERICA to Reveal Newly Designed Responsive Website at INTERPHEX 2015 Today 2HOLLOWAY AMERICA to Reveal Newly Designed Responsive Website at INTERPHEX 2015 Today 3Fastec Imaging Releases the TS5-H High Definition High-Speed Camera 2Fastec Imaging Releases the TS5-H High Definition High-Speed Camera 3YourEncore and ACRES Partner to Drive Innovation in Clinical Research 2YourEncore and ACRES Partner to Drive Innovation in Clinical Research 3
... Feb. 7 ACCESS PHARMACEUTICALS, INC.,(OTC Bulletin Board: ACCP) ... Access, is scheduled to deliver a presentation about the ... on February 13, 2008 at,12:30 pm Eastern Time. The ... City at the Waldorf Astoria Hotel., The presentation ...
... 7 Neurobiological,Technologies, Inc. (NTI(R)) (Nasdaq: NTII ), ... results, for the quarter ended December,31, 2007, on February ... the earnings and to give a corporate update., ... and Chief Executive,Officer, and Craig W. Carlson, Vice President ...
... -- Total segment operating profit increased 77% when compared to the same ... posting 14% volume growth in the quarter, -- Fertilizer continued ... Financial Highlights (In millions, except per share data and percentages), ... Quarter Ended ...
Cached Biology Technology:Access Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference 2Bunge Reports Fourth Quarter Net Income of $245 Million 2Bunge Reports Fourth Quarter Net Income of $245 Million 3Bunge Reports Fourth Quarter Net Income of $245 Million 4Bunge Reports Fourth Quarter Net Income of $245 Million 5Bunge Reports Fourth Quarter Net Income of $245 Million 6Bunge Reports Fourth Quarter Net Income of $245 Million 7Bunge Reports Fourth Quarter Net Income of $245 Million 8Bunge Reports Fourth Quarter Net Income of $245 Million 9Bunge Reports Fourth Quarter Net Income of $245 Million 10Bunge Reports Fourth Quarter Net Income of $245 Million 11Bunge Reports Fourth Quarter Net Income of $245 Million 12Bunge Reports Fourth Quarter Net Income of $245 Million 13Bunge Reports Fourth Quarter Net Income of $245 Million 14Bunge Reports Fourth Quarter Net Income of $245 Million 15Bunge Reports Fourth Quarter Net Income of $245 Million 16Bunge Reports Fourth Quarter Net Income of $245 Million 17Bunge Reports Fourth Quarter Net Income of $245 Million 18Bunge Reports Fourth Quarter Net Income of $245 Million 19Bunge Reports Fourth Quarter Net Income of $245 Million 20
(Date:3/20/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/rswjb4/hand_geometry ) ... Global Strategic Business Report" report to their offering. ... in US$ Thousands. The report provides separate comprehensive analytics for ... , Europe , Asia-Pacific ... of World. Annual estimates and forecasts are provided ...
(Date:3/20/2015)... and Markets ( http://www.researchandmarkets.com/research/vkzvcs/iris_biometrics ) has announced the ... Report" report to their offering. This report ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... . Annual estimates and forecasts are provided ...
(Date:3/18/2015)... Florida , March 18, 2015 ... as businesses, new revolutionary smart wallets and apps continue to ... Companies currently entrenched in the mobile payment industry in focus ... Group Holding Ltd. (NYSE: BABA ), Apple Inc. ... GOOG ) and Facebook Inc. (NASDAQ: FB ) ...
Breaking Biology News(10 mins):Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 2Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 3Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 4Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 5Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 6
... Tampa, Fla. (Jan. 28, 2008) According to two ... (Vol.16 No.10), stroke victims may benefit from human mesenchymal ... transplantation. In both studies, the migration of chemically tagged ... to which the transplanted cells reached damaged areas of ...
... anthrax uses to enter healthy cells has been uncovered ... (UAB). Anthrax spores enter the cell through something ... of certain cells. This is the first study ... to begin with, the UAB researchers said. Previous studies ...
... new Center for Vaccine Awareness and Research at Texas ... first major cocoon strategy vaccination program to protect newborn ... as whooping cough. , Whooping cough is a highly-contagious ... can occur at any age, whooping cough can be ...
Cached Biology News:Stroke victims may benefit from stem cell transplants 2Anthrax cellular entry point uncovered 2Texas Hospital nation's first to use large-scale 'cocoon strategy' against whooping cough 2